Design of phenytoinergic anticonvulsants: The series of retrobenzamides;CONCEPTION RATIONNELLE, SYNTHESE ET EVALUATION D'AGENTS ANTICONVULSANTS ORIGINAUX A POTENTIALITE PHENYTOINERGIQUE

Journal de Pharmacie de Belgique

Volumn 52, Issue 5, 1997, Pages 181-189

  Bourhim, Mustapha ^a   Kanyonyo, Martial D ^b   Lambert, Didier M ^b   Poupaert, Jacques H ^b   Stables, James P ^c   Vamecq, Joseph ^a,d  

^a INSERM   (France)

^b U de Chim Therapeutique   (Belgium)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMELTOLIDE; ANTICONVULSIVE AGENT; BENZAMIDE DERIVATIVE; CARBAMAZEPINE; PENTETRAZOLE; PHENYTOIN; RETROBENZAMIDE DERIVATIVE; UNCLASSIFIED DRUG; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG DESIGN; DRUG SYNTHESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; HUMAN; SYNTHESIS;

ANIMALS; ANTICONVULSANTS; BENZAMIDES; DRUG DESIGN; HUMANS; MICE; PHENYTOIN; RATS;

EID: 0031217335     PISSN: 00472166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. HAUSER WA. The prevalence and incidence of convulsive disorders in children. Epilepsia 1994; 35, Suppl. 2: S1-S6.
2. PARRAIN D. De la crise épileptique à l'épilepsie. Dans: Pons G, Dulac O & Ben-Ary Y, Eds. Les médicaments antiépileptiques chez l'enfant (Collection «Recherche Clinique et Décision Thérapeutique» dirigée par Caulin C & Chastang C). Springer Verlag France, Paris, 1994; pp 27-35.
3. LÖSHER W & SCHMIDT D. Which animal model should be used in the search for the new antiepileptic drugs. A proposal based on experimental and clinical considerations. Epilepsy Res 1988; 2: 145-181.
4. LOUVEL J. Mécanismes d'action des antiépileptiques. Dans: Pons G, Dulac O & Ben-Ary Y, Eds; Les médicaments antiépileptiques chez l'entant (Collection «Recherche Clinique et Décision Thérapeutique» dirigée par CAULIN C & CHASTANG C). Springer Verlag France, Paris, 1994; pp 69-85.
5. VALLÉE L, CUVELIER JC & VAMECQ J. Dans: PONS G, DULAC O & BEN-ARY Y, Eds. Les médicaments antiépileptiques chez l'enfant (Collection «Recherche Clinique et Décision Thérapeutique» dirigée par CAULIN C & CHASTANG C). Springer Verlag France, Paris, 1994; pp 107-125.
6. PELLOCK JM. Carbamazépine side effects in children and adults. Epilepsia 1987; 28, Suppl 3: S64-S70
7. CLARK C.R. Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimethylphenyl) benzamide and prototype antiepileptic drugs in mice and rats. Epilepsia 1988; 29: 198-203.
8. LEANDER JD; LAWSON RR & ROBERTSON DW. Anticonvulsant effects of a novel aminobenzamide (LY201116) in mice. Neuropharmacology 1988; 27: 623-628.
9. BAILLEUX V, VALLÉE L, NUYTS JP & VAMECQ J. Original anticonvulsant properties of two N-phenylphthalimide derivatives. Biomed & Pharmacother 1993; 47: 463-464.
10. BAILLEUX V, VALLÉE L, NUYTS JP & VAMECQ J. Anticonvulsant activity of some 4-amino-N-phenylphthalimide and N-(3-amino-2-methylphenyl)phthalimides. Biomed & Pharmacother 1994; 48: 95-101.
11. BAILLEUX V, VALLÉE L, NUYTS JP & VAMECQ J. Synthesis and anticonvulsant activity of some N-phenylphthalimides. Chem. Pharm. Bull 1994; 42: 1817-1821.
12. BAILLEUX V, VALLÉE L, NUYTS JP, HAMOIR G, POUPAERT JH, STABLES J & VAMECQ J. Comparative anticonvulsant activity and neurotoxicity of 4-amino-N-(2,6-dimethylpheny)phthalimide and prototype antiepileptic drugs in mice and rats. Epilepsia 1995; 36: 559-565.
13. DIOUF O, BOURHIM M, LAMBERT DM, POUPAERT JH, STABLES J & VAMECQ J. Anticonvulsant and neurotoxicological properties of 4-amino-N-(2-ethylphenyl)benzamide, a potent ameltolide analogue. Biomed & Pharmacother 1997; 51: 131-136.
14. KRALL RL, PENRY JK, WHITE BG, KUPFERBERG HJ & SWINYARD EA. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 1978; 19: 409-28.
15. PORTER RJ, CEREGHINO JJ, GLADDING GD, HESSIE BJ, KUPFERBERG HJ, SCOVILLE B & WHITE BG Antiepileptic Drug Development Program. Cleve Clin. J. Med 1984; 51: 293-305.
16. BAILLEUX V, VALLÉE L, NUYTS JP, HAMOIR G, POUPAERT JH, STABLES J & VAMECQ J. Synthesis and amiconvulsant activity of some 4-nitro-N-phenylbenzamides. Eur J. Med. Chem. 1995; 30: 439-444.
17. POTTS BD, STEVE G & PARLI CJ. Metabolism, disposition and pharmacokinetics of a potent anticonvulsant 4-amino-N-(2,6-dimethyl phenyl)benzamide (LY 201116) in rats. Drug. Metab. Disp. 1989; 17: 656-661.
18. WILLOW M & CATTERALL WA. Inhibition of binding of [3H]batrachotoxinin A 20-a-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine. Mol. Pharmacol 1982; 22: 627-635.
19. BROWN GB. Batrachotoxin, a window on the allosteric nature of the voltage-sensitive sodium channels. Int; Rev. Neurobiol 1988; 29: 77-116.
20. MACDONALD RL & KELLY KM. Antiepileptic drug mechanisms of action. Epilepsia 1995; 36 (Suppl 2): S2-S12.